Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 169 results for "julie masow"

Novartis: FDA Approves First IL-17A Antagonist Cosentyx for Mo...

Press Release: Novartis announces FDA approval for first IL-17A antagonist Cosentyx(TM) (secukinumab) for moderate-to-severe plaque psoriasis patients Novartis announces FDA approval for first IL-17A antagonist Cosentyx(TM) (secukinumab) for ... iMarketReports, 1 week ago

NOVARTIS : restructuring; up to 200 to lose jobs

Novartis Pharmaceuticals Corporation is eliminating as many as 200 jobs in East Hanover as part of a restructuring. In October, the Swiss drugmaker said, itrealigned its business units, creating what it calls a cardiovascular field force from its ...
 4 Traders4 weeks ago Novartis AG Eliminating Up To 200 Jobs At U.S. Headquarters  BioSpace1 month ago

Six-year pivotal study data reinforce the superiority of Tasigna® over Gleevec® in newly-diagnosed patients with Ph+ CML

EAST HANOVER, N.J., Dec. 8, 2014 /PRNewswire/ -- Six-year results from the randomized Phase III ENESTnd study continue to demonstrate the superiority of Tasigna (nilotinib) compared to Gleevec (imatinib mesylate)[*] at achieving higher rates of ...
 BusinessWeek1 month ago

NOVARTIS : To Reduce Workforce In East Hanover

Novartis had announced in October 2014 that the company realigned its business units, forming a cardiovascular field force from its team focused on primary care. Novartis spokeswoman Julie Masow said that however, the company's anticipated needs ...
 4 Traders1 month ago

Novartis lays off 200 primary care reps as it preps for megablockbuster LCZ696 rollout

Even a megablockbuster launch isn't enough to save Novartis ($NVS) sales reps targeted for job cuts. The company is laying off 200 primary care sales folks in New Jersey as it rejigs its sales operation and prepares to launch LCZ696, a hotly ...
 FiercePharma1 month ago

Novartis highlights new CTL019 clinical data showing complete remissions in children and young adults with relapsed/refractory acute lymphoblastic leukemia

EAST HANOVER, N.J. , Dec. 6, 2014 /PRNewswire/ --Findings from continued clinical studies of investigational chimeric antigen receptor (CAR) therapy, CTL019, demonstrate its potential role in the treatment of certain types of lymphocytic leukemia.
 SearchBug1 month ago

Novartis features innovative immunotherapy, targeted pipeline treatment combinations and long-term data at ASH and SABCS 2014

EAST HANOVER, N.J., Dec. 2, 2014 /PRNewswire/ -- Novartis will highlight more than 250 abstracts demonstrating advances in blood and breast cancer research at the upcoming American Society of Hematology (ASH) annual meeting December 6-9, and ...
 Financial Content1 month ago

Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually

EAST HANOVER, N.J. , Nov. 18, 2014 /PRNewswire/ --A new global survey of more than 10,000 adults in 10 countries finds that a large majority of the general public feel they know little or nothing about lung cancer (84%), a devastating disease that ...
 Tamar Securities2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less